Recent Formulations of Hormonal Birth Control Reduce Ovarian Cancer Risk, Researchers Report

Recent Formulations of Hormonal Birth Control Reduce Ovarian Cancer Risk, Researchers Report
Combined oral contraceptives — containing both smaller doses of estrogens plus newer progestogens — are associated with a decreased risk of ovarian cancer in women younger than 50, a large study suggests. The research, “Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study,” was published in

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *